- Home
- SCNI vs VERO Comparison
SCNI vs VERO Comparison
Compare SCNI & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- VERO
- Stock Information
- Founded
- SCNI 2003
- VERO N/A
- Country
- SCNI Israel
- VERO Canada
- Employees
- SCNI N/A
- VERO N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- VERO Medical/Dental Instruments
- Sector
- SCNI Health Care
- VERO Health Care
- Exchange
- SCNI Nasdaq
- VERO Nasdaq
- Market Cap
- SCNI 1.9M
- VERO 2.2M
- IPO Year
- SCNI N/A
- VERO N/A
- Fundamental
- Price
- SCNI $2.55
- VERO $3.18
- Analyst Decision
- SCNI
- VERO
- Analyst Count
- SCNI 0
- VERO 0
- Target Price
- SCNI N/A
- VERO N/A
- AVG Volume (30 Days)
- SCNI 1.1M
- VERO 3.1M
- Earning Date
- SCNI 07-01-2025
- VERO 05-15-2025
- Dividend Yield
- SCNI N/A
- VERO N/A
- EPS Growth
- SCNI N/A
- VERO N/A
- EPS
- SCNI N/A
- VERO N/A
- Revenue
- SCNI $658,000.00
- VERO $60,997,000.00
- Revenue This Year
- SCNI N/A
- VERO N/A
- Revenue Next Year
- SCNI N/A
- VERO $7.47
- P/E Ratio
- SCNI N/A
- VERO N/A
- Revenue Growth
- SCNI N/A
- VERO N/A
- 52 Week Low
- SCNI $1.90
- VERO $2.10
- 52 Week High
- SCNI $8.92
- VERO $17.49
- Technical
- Relative Strength Index (RSI)
- SCNI 46.70
- VERO 65.91
- Support Level
- SCNI $2.32
- VERO $2.31
- Resistance Level
- SCNI $6.18
- VERO $2.49
- Average True Range (ATR)
- SCNI 0.41
- VERO 0.24
- MACD
- SCNI -0.01
- VERO 0.09
- Stochastic Oscillator
- SCNI 8.10
- VERO 50.00
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.